Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
about
Helicobacter pylori eradication for the prevention of gastric neoplasiaSerum Helicobacter pylori KatA and AhpC antibodies as novel biomarkers for gastric cancerHelicobacter pylori in gastric carcinogenesisMolecular cancer prevention: Current status and future directionsEthnic differences in gastric cancer genetic susceptibility: allele flips of interleukin geneEpidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this diseaseAdhesion and Invasion of Gastric Mucosa Epithelial Cells by Helicobacter pyloriDiverging breast and stomach cancer incidence and survival in migrants in The Netherlands, 1996-2009.Nature meets nurture: molecular genetics of gastric cancer.Diet and lifestyle factors and risk of subtypes of esophageal and gastric cancers: classification tree analysis.Association of Helicobacter pylori infection and diet on the risk of gastric cancer: a case-control study in HawaiiHelicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development.Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trialsCirculating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled studyHelicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: a retrospective case-control study.H. pylori seropositivity before age 40 and subsequent risk of stomach cancer: a glimpse of the true relationship?At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.Effects of interleukin-10 polymorphisms, Helicobacter pylori infection, and smoking on the risk of noncardia gastric cancer.Helicobacter pylori seropositivity and risk of lung cancer.Gastric cancer: an infectious diseasePre-existing diabetes mellitus increases the risk of gastric cancer: a meta-analysis.Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC studyHelicobacter pylori Seropositivity Is Associated with Gastric Cancer Regardless of Tumor Subtype in KoreaIncreased risk of stomach and esophageal malignancies in people with AIDS.Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers.Clinical significance of MYT1L gene polymorphisms in Chinese patients with gastric cancer.Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort.Principal component analysis of dietary and lifestyle patterns in relation to risk of subtypes of esophageal and gastric cancer.The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas.Pyridodiazepine amines are selective therapeutic agents for helicobacter pylori by suppressing growth through inhibition of glutamate racemase but are predicted to require continuous elevated levels in plasma to achieve clinical efficacyShrinkage of the human core microbiome and a proposal for launching microbiome biobanks.Risk of gastric cancer by water source: evidence from the Golestan case-control studyProspective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohortTwo distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori statusFactors predicting survival in patients with proximal gastric carcinoma involving the esophagus.Fatty acids in a high-fat diet potentially induce gastric parietal-cell damage and metaplasia in mice.Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinoma.Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies.Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients.
P2860
Q24186365-F3E3C9E0-0AE0-45CB-AE8B-D087198D416BQ24658605-FE26C7AE-E824-4541-8A81-F98BFF3D2266Q26774101-B707B3EE-E5BF-417B-8EA5-071081BBEBBDQ26797207-CFD63A2C-7B01-42E4-B9BD-3931185E653DQ27014119-1FDF8F71-7792-4E7F-853A-3CE25D4EFCCFQ27027061-FE090605-5A2C-4683-A728-34E9F5B2EEBAQ28080151-94E2744F-D463-4BBD-A34E-51CEF8F82238Q29353777-95494578-DA5F-4DBA-85A5-8791C24175D2Q33347546-71046B09-2BC9-4FF3-BA73-3C59D45B0F7CQ33554117-3635E059-8648-434D-A649-E48DD74DCC1EQ33561421-802E9DCF-0FA8-488D-A9AA-C8F3D9E8F06BQ33594937-097A7B0D-2081-414D-AE01-2E95C9E63C18Q33636554-066343DB-A20B-4101-85EA-E7A29577E0CFQ33742692-33ADE865-4DBB-41F8-AA52-CDB2B7886634Q33810991-B75ED805-81B6-4C10-A609-61CBE6ACC481Q33844717-CE2980B9-DAAA-42B6-8DC1-0EFBF5EA56C1Q33911623-B8FD2C0C-FBB7-4E00-8B07-20FB88729C63Q34123807-4205BEE3-2937-41D3-B0A6-56C982E94646Q34182270-9C625913-4900-4DAF-835F-A0D745C8A7D6Q34194651-C7308A7F-19FB-4346-B08D-36FB379AC8B4Q34328991-280FC53E-0FDE-410A-85CA-1EBD1E340CC4Q34438569-C64B3648-F5A4-42C9-B27B-51DB96831B60Q34494041-E08B7332-A664-4CC9-94E9-3A86DA6B4465Q34535134-17EC8CBC-FBFC-464B-A338-FC92DBE6A151Q34620280-5F453786-364D-40B7-95C5-A28195286623Q34949732-BAFA46FE-16B6-480F-81CB-9711B2A1CF1DQ34981334-6C2E4852-84C7-49C9-A72D-13BDE2C96C55Q35006927-33B1B8C3-2653-4567-BFAF-56FC34E19FBEQ35028384-950F1674-969A-42A4-B8BB-586DD6A8CFFDQ35115249-9D191C36-764B-43B1-B741-1C33DEB77510Q35169043-7B17A768-7544-4EF0-B5C8-51EBE30556E5Q35193531-3B3202D0-BE0F-4CBE-82D7-4A16F94D0894Q35645977-09DE13D8-EA3C-4ADB-A4FD-24AF6A00B771Q35930331-1568C476-66DF-4015-9EF1-12C9FA64AF02Q36013985-9FD0B47F-828F-4B0D-851F-8C03BDC93830Q36105566-D0852B42-C704-4738-8650-6C954E90744AQ36200666-037AD94B-C2F0-41B7-AE2F-FEEC0E23146EQ36291354-DC46CB77-296F-4A79-AE67-2DD4309C6AE3Q36309934-D98A337C-1216-4EAE-AE12-B01F43665860Q36352133-99E50820-912F-4E5B-B04C-E4763205418B
P2860
Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Opposing risks of gastric card ...... obacter pylori seropositivity.
@en
Opposing risks of gastric card ...... obacter pylori seropositivity.
@nl
type
label
Opposing risks of gastric card ...... obacter pylori seropositivity.
@en
Opposing risks of gastric card ...... obacter pylori seropositivity.
@nl
prefLabel
Opposing risks of gastric card ...... obacter pylori seropositivity.
@en
Opposing risks of gastric card ...... obacter pylori seropositivity.
@nl
P2093
P50
P356
P1476
Opposing risks of gastric card ...... obacter pylori seropositivity.
@en
P2093
Craig J Newschaffer
Farin Kamangar
Guillermo I Perez-Perez
Philip R Taylor
Pirjo Pietinen
Sanford M Dawsey
P304
P356
10.1093/JNCI/DJJ393
P407
P577
2006-10-01T00:00:00Z